Public Policy: Antitrust & Antibiotics

The running battle that has raged for the past three years between the Government and the U.S. drug industry was shifted last week to the courts. Charging conspiracy to fix prices and limit competition, the Justice Department won a grand jury antitrust indictment against three of the nation's largest antibiotic producers and their chief executives. The defendants: American Cyanamid and its chairman, Wilbur G. Malcolm; Charles Pfizer & Co. and Chairman John E. McKeen; Bristol-Myers Co. and President Frederic N. Schwartz.

The antibiotics cited in the Justice Department suit are aureomycin, terramycin'...

Want the full story?

Subscribe Now

Subscribe
Subscribe

Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on TIME.com

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!